Coriell Institute For Medical Research Inc

Programs: Coriell institute for medical research, founded in 1953 and based in camden, new jersey, is an independent non-profit research institute dedicated to the study of the human genome. Expert staff and pioneering programs in the fields of personalized medicine, cell biology, cytogenetics, genotyping, and biobanking drive our mission. The institute maintains repositories for cell lines and dna and distributes over 20,000 biomaterials annually to researchers nationally and internationally. The coriell personalized medicine collaborative (cpmc) research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision-making and healthcare management. Coriell has a distinguished history in cell biology, pursuing currently induced pluripotent stem (ips) cell research. These powerful cells are revolutionizing the way human disease is studied and how drugs are developed. Coriell offers custom research services including cell culture, cytogenetic analyses, and molecular biology. Its clia-certified genotyping and microarray center offers high-throughput dna analysis systems using the platforms of two leading providers. Essential to the institute's support of international scientific research is the coriell biobank. From this renowned cell bank, coriell manages and distributes the world's most diverse collection of cell lines, dna, and other biological resources. The coriell biobank provided support to the human genome project, a worldwide program to map the entire human genome, and to the international hapmap project, a project providing an efficient tool to identify disease-causing genes. Coriell's biobanking operation is funded by several national institutes of health awards.